PDCD1LG2 and neoplasm: Additionally, it had been found that PD-L2 was also involved in intracellular signaling pathways to promote tumor cell migration, invasion, and induce drug resistance indicating that PD-L2 expression on tumor cells was also involved in evading antitumor immunity (11, 12).